https://clinicaltrials.gov/ct2/show/NCT03645434?type=Intr&cond=COPD&phase=01234&lupd_s=10%2F25%2F2018&lupd_d=14&sort=nwst A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases. Condition : Chronic Obstructive Pulmonary Disease Interventions : Drug: AZD8871; Drug: Anoro® Ellipta® Sponsors : AstraZeneca; Parexel Recruiting NCT03645434 Fri, 24 Aug 2018 12:00:00 EDT